Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin on Trauma-Associated Memories
NCT03031405Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2017
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray in post-traumatic stress disorder (PTSD), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Intrusive memories at 4 days. Started Jan 2017; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03031405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03031405.